These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6294642)

  • 61. [Tumors of ovary and testis (author's transl)].
    De Jager R
    Rev Med Brux; 1980 May; 1(5):315-20. PubMed ID: 6258206
    [No Abstract]   [Full Text] [Related]  

  • 62. Synthesis of 4-hydroperoxy derivatives of ifosfamide and trofosfamide by direct ozonation and preliminary antitumor evaluation in vivo.
    Hohorst HJ; Peter G; Struck RF
    Cancer Res; 1976 Jul; 36(7 PT 1):2278-81. PubMed ID: 945124
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The anticancer spectrum of ifosfamide.
    Hunter HL; Harrison EF
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):96-100. PubMed ID: 6761868
    [No Abstract]   [Full Text] [Related]  

  • 64. Ifosfamide: chemotherapy with new promise and new problems for the urologist.
    Watson RA
    Urology; 1984 Nov; 24(5):465-8. PubMed ID: 6495457
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ifosfamide--pharmacology, safety and therapeutic potential.
    Brade WP; Herdrich K; Varini M
    Cancer Treat Rev; 1985 Mar; 12(1):1-47. PubMed ID: 3896483
    [No Abstract]   [Full Text] [Related]  

  • 66. [Clinical evaluation of Iphosphamide in phracological treatment of neoplasms].
    Madej G; Zelechowska JA
    Pol Tyg Lek; 1975 Jun; 30(22):955-7. PubMed ID: 1135071
    [No Abstract]   [Full Text] [Related]  

  • 67. Ifosfamide approved for treatment of testicular cancer.
    Oncology (Williston Park); 1989 Mar; 3(3):120. PubMed ID: 2641316
    [No Abstract]   [Full Text] [Related]  

  • 68. [Chemotherapy of malignant melanoma with cis-diaminodichloroplatinum and ifosfamid (author's transl)].
    Berdel WE; Fink U; Emmerich B; Maubach PA; Busch U; Remy W; Rastetter J
    Dtsch Med Wochenschr; 1982 Jan; 107(1):26-8. PubMed ID: 7198963
    [No Abstract]   [Full Text] [Related]  

  • 69. [Mithramycin in advanced malignant testicular tumors].
    Klepp O; Hóst H; Klepp R; Lien HH; Tausjó J
    Tidsskr Nor Laegeforen; 1975 Jan; 95(1):23-8. PubMed ID: 163041
    [No Abstract]   [Full Text] [Related]  

  • 70. Use and safety of high-dose ifosfamide.
    Holoye PY; Anderson T; Duelge J; Hansen RM; Ritch PS
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):78-86. PubMed ID: 6298946
    [No Abstract]   [Full Text] [Related]  

  • 71. In germ cell cancer, are we at the end of the chemotherapy era? Maybe--and we are certainly at the end of the RCT era.
    Maroni P
    Oncology (Williston Park); 2013 Nov; 27(11):1136, 1143. PubMed ID: 24575541
    [No Abstract]   [Full Text] [Related]  

  • 72. Etoposide and etoposide-ifosfamide therapy for refractory testicular tumors.
    Bremer K; Niederle N; Krischke W; Higi M; Scheulen ME; Schmidt CG; Seeber S
    Cancer Treat Rev; 1982 Jun; 9 Suppl():79-84. PubMed ID: 7127338
    [No Abstract]   [Full Text] [Related]  

  • 73. Ifosfamide.
    Zalupski M; Baker LH
    J Natl Cancer Inst; 1988 Jun; 80(8):556-66. PubMed ID: 3286879
    [TBL] [Abstract][Full Text] [Related]  

  • 74. N-acetylcysteine and ifosfamide in the treatment of unresectable pancreatic adenocarcinoma and refractory testicular cancer.
    Loehrer PJ; Williams SD; Einhorn LH
    Semin Oncol; 1983 Mar; 10(1 Suppl 1):72-5. PubMed ID: 6836331
    [No Abstract]   [Full Text] [Related]  

  • 75. In germ cell cancer, are we at the end of the chemotherapy era? No-targeted therapies have not heralded its demise.
    Raghavan D
    Oncology (Williston Park); 2013 Nov; 27(11):1137, 1143. PubMed ID: 24575542
    [No Abstract]   [Full Text] [Related]  

  • 76. Targeted therapies in germ cell tumors.
    Squillante CM; Vaughn DJ
    Urol Oncol; 2015 Aug; 33(8):363-9. PubMed ID: 25544153
    [No Abstract]   [Full Text] [Related]  

  • 77. Why balls are not put inside the basket? A reflection on testicular cancer clinical trial design.
    Kourie HR; Aoun F
    Invest New Drugs; 2016 Aug; 34(4):513-4. PubMed ID: 26960332
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Urologic oncology: Poor trial accrual hinders germ cell tumor therapy advances.
    Williams MV; Mazhar D
    Nat Rev Urol; 2012 Apr; 9(5):243-5. PubMed ID: 22472588
    [No Abstract]   [Full Text] [Related]  

  • 79. Ifosfamide as single-agent chemotherapy in inoperable non-small-cell lung cancer.
    Peake MD; Parker D
    Lancet; 1985 Aug; 2(8453):496-7. PubMed ID: 2863510
    [No Abstract]   [Full Text] [Related]  

  • 80. Phase I clinical trial of a 3-day divided dose schedule of ifosfamide (NSC 109724).
    Nelson RL; Creaven PJ; Cohen MH; Fossieck BE
    Eur J Cancer (1965); 1976 Mar; 12(3):195-8. PubMed ID: 780113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.